Home » Stocks » NWBO » Company

Northwest Biotherapeutics, Inc. (NWBO)

Stock Price: $1.45 USD -0.01 (-0.34%)
Updated Jun 22, 2021 3:59 PM EDT - Market closed
Northwest Biotherapeutics, Inc.
Country United States
Founded 1996
Industry Biotechnology
Sector Healthcare
Employees 19
CEO Linda Powers

Contact Details

Address:4800 Montgomery Ln Ste 800
Bethesda, Maryland 20814-3676
United States
Phone 240 497 9024

Stock Information

Ticker Symbol NWBO
Exchange OTCMKTS
Fiscal Year January - December
Reporting Currency US Dollars
CIK Code 0001072379
CUSIP Number 66737P105
ISIN Number US66737P6007
Employer ID 94-3306718

Company Description

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally.

The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer.

Its lead product, DCVax-L that is in Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, which is in Phase I/II clinical trials to treat inoperable solid tumors.

The company was founded in 1996 and is headquartered in Bethesda, Maryland.

Key Executives

Linda F. Powers J.D.Chairperson, Chief Executive Officer, President, Chief Financial Officer and Chief Accounting Officer
Dr. Alton L. BoyntonFounder, Chief Scientific Officer, Secretary and Director
Dr. Marnix L. Bosch M.B.A., Ph.D., MBAChief Technical Officer
Leslie J. GoldmanSenior Vice President and General Counsel
Jean M. DavisChief Information Officer
David InnesVice President of Investor Relations
Pankaj R. Shah C.A., CPAFinancial Controller